文献速递神经MRCT

联合高信号FLAIR环与影像学特征识别IDH突变型1p/19q非共缺失低级别胶质瘤

Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma.
PubMed 文献 · Eur Radiol · 2022-01-25

该回顾性研究纳入585例成人弥漫性低级别胶质瘤(组织学2-3级),按手术日期2:1分为训练队列A(390例)和验证队列B(195例),评估术前MRI和CT特征。高信号FLAIR环伴低信号核心(hyperFLAIRrim)在定义IDH突变型1p/19q非共缺失星形细胞瘤时较T2-FLAIR错配更敏感(队列A敏感度0.713 vs 0.539;队列B 0.713 vs 0.489),且特异度均为1.00。联合hyperFLAIRrim、较高rADC、T2WI均匀模式、无钙化和年轻年龄的随机森林模型预测能力最佳。

要点

  • hyperFLAIRrim征(高信号FLAIR环伴低信号核心)诊断IDHmut-Noncodel星形细胞瘤的敏感度在队列A为0.713、队列B为0.713,特异度均为1.00。
  • T2-FLAIR错配诊断IDHmut-Noncodel的敏感度在队列A为0.539、队列B为0.489,特异度均为1.00。
  • 联合hyperFLAIRrim、较高rADC、T2WI均匀模式、无钙化和年轻年龄的随机森林模型预测能力最佳。

核心结论

  • hyperFLAIRrim征是诊断IDHmut-Noncodel星形细胞瘤的特异性且更敏感的征象;联合hyperFLAIRrim、较高rADC、均匀模式、无钙化和年轻年龄可精确预测胶质瘤亚型以辅助制定手术方案。

研究设计与样本

  • 回顾性研究,连续纳入2013年12月1日至2020年12月31日诊断为弥漫性低级别胶质瘤(组织学2-3级)的成人患者585例,按手术日期2:1分为训练队列A(390例)和验证队列B(195例),记录并分析临床和影像学特征。

关键影像表现/征象

  • hyperFLAIRrim表现为高信号FLAIR环伴低信号核心,不论T2表现如何。
  • T2WI均匀模式与IDHmut-Noncodel星形细胞瘤相关。
  • 无钙化与IDHmut-Noncodel星形细胞瘤相关。

诊断标准与关键数值

  • hyperFLAIRrim诊断IDHmut-Noncodel星形细胞瘤的敏感度:队列A为0.713,队列B为0.713;特异度均为1.00。
  • T2-FLAIR错配诊断IDHmut-Noncodel星形细胞瘤的敏感度:队列A为0.539,队列B为0.489;特异度均为1.00。

临床应用与阅片要点

  • 术前MRI和CT可用于诊断IDHmut-Noncodel以指导手术方案制定。
  • 神经外科医生应对影像学提示的IDHmut-Noncodel星形细胞瘤采取更积极的切除策略以延长生存。
  • 本研究为神经外科医生制定个体化手术策略提供了可用、可行和可靠的方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Even very small residual tumors of IDH mutant 1p/19q non-codeleted (IDHmut-Noncodel) astrocytoma could have a significantly negative impact on survival; thus, accurate preoperative diagnosis is of utmost importance to guide aggressive tumor resection strategy for this subtype. This study aimed to diagnose IDHmut-Noncodel from IDH mutant 1p/19q codeleted (IDHmut-Codel) and IDH wild-type gliomas by preoperative MRI and CT to guide surgical plan-making.

METHODS: Consecutive adult patients diagnosed with diffuse lower-grade glioma (LGG, histological grade 2-3) from December 1, 2013 to December 31, 2020, were retrospectively included in this study. Clinical and radiological features were recorded and analyzed. Patients were divided into cohort A and cohort B for training and validation based on the operation date (2:1).

RESULTS: A total of 585 patients were included in this study (cohort A, 390; cohort B, 195). The hyperintense FLAIR rim with hypointense core (hyperFLAIRrim) was a more sensitive sign than T2-FLAIR mismatch (T2FM) in defining IDHmut-Noncodel astrocytoma (sensitivity in cohort A: 0.713, 0.539, respectively; in cohort B: 0.713, 0.489, respectively) without compromised specificity (all 1.00). The hyperFLAIRrim, higher rADC, homogenous pattern on T2WI, non-calcification, and younger age were the most important factors associated with IDHmut-Noncodel astrocytoma. Combining these factors, the random forest model showed the best predictive ability.

CONCLUSION: The hyperFLAIRrim sign was a specific and more sensitive sign in diagnosing IDHmut-Noncodel astrocytoma. Combining hyperFLAIRrim, higher rADC, homogenous pattern, non-calcification, and younger age could precisely predict glioma subtype for subsequent surgical plan-making.

KEY POINTS: • A single hyperintense FLAIR rim (hyperFLAIRrim) sign with a hypointense core, regardless of T2 appearance, was more sensitive than T2FM in diagnosing IDHmut-Noncodel astrocytoma with high specificity. • The higher rADC value, homogenous pattern on T2WI, non-calcification, and younger age have a close relationship with IDHmut-Noncodel astrocytoma. • Neurosurgeons should perform a more aggressive resection strategy to prolong survival for radiologically indicated IDHmut-Noncodel astrocytoma. Our study provided a usable, practicable, and reliable protocol for neurosurgeons to make an individualized surgical strategy.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li, Ren, Chen, et al. Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma. Eur Radiol. 2022. PMID: 35079884. doi:10.1007/s00330-021-08500-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。